We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$38.8B
AUM Growth
+$957M
(+2.5%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
18.92%
Holding
4,122
New
310
Increased
2,005
Reduced
1,517
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$140M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$87.2M |
| 3 |
CMCT
Creative Media & Community Trust
CMCT
|
+$51.6M |
| 4 |
HECA
Hedgeye Capital Allocation ETF
HECA
|
+$43.6M |
| 5 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.4M |
| 2 |
iShares S&P 100 ETF
OEF
|
+$31.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$29.4M |
| 4 |
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
|
+$25.4M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$24.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.12% |
| 2 | Financials | 4.47% |
| 3 | Industrials | 3.2% |
| 4 | Consumer Discretionary | 3.13% |
| 5 | Communication Services | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RZLV
3801
Rezolve AI
RZLV
$1.07B
| $95K | ﹤0.01% |
37,300
+6,184
| +20% | +$17.4K |
|
|
CMU
3802
DELISTED
MFS High Yield Municipal Trust
CMU
| $94K | ﹤0.01% |
26,138
+87
| +0.3% | +$310 |
|
|
FTNJ
3803
Franklin New Jersey Municipal Income ETF
FTNJ
$173M
| $94K | ﹤0.01% |
10,806
| – | – |
|
3804
Vir Biotechnology
VIR
$1.52B
| $93K | ﹤0.01% |
10,355
| – | – |
|
3805
Algonquin Power & Utilities
AQN
$4.44B
| $92K | ﹤0.01% |
14,986
-430
| -3% | -$2.79K |
|
3806
LifeMD
LFMD
$159M
| $92K | ﹤0.01% |
25,500
| – | – |
|
3807
Lightwave Logic
LWLG
$1.23B
| $92K | ﹤0.01% |
13,021
| – | – |
|
3808
Nordic American Tanker
NAT
$1.36B
| $88K | ﹤0.01% |
14,991
-2,138
| -12% | -$10.1K |
|
3809
First Guaranty Bancshares
FGBI
$139M
| $87K | ﹤0.01% |
+10,734
| New | +$90.3K |
|
3810
Under Armour
UAA
$2.26B
| $87K | ﹤0.01% |
14,762
-908
| -6% | -$5.89K |
|
3811
Asure Software
ASUR
$241M
| $86K | ﹤0.01% |
10,000
-103
| -1% | -$909 |
|
3812
Riverview Bancorp
RVSB
$106M
| $82K | ﹤0.01% |
14,876
+3,681
| +33% | +$19.4K |
|
3813
Veritone
VERI
$141M
| $82K | ﹤0.01% |
41,480
+30,287
| +271% | +$102K |
|
3814
AtaiBeckley Inc
ATAI
$2.68B
| $81K | ﹤0.01% |
22,891
+2,255
| +11% | +$8.49K |
|
|
HIVE
3815
HIVE Digital Technologies
HIVE
$750M
| $80K | ﹤0.01% |
41,882
-3,771
| -8% | -$9.3K |
|
3816
Puma Biotechnology
PBYI
$459M
| $80K | ﹤0.01% |
12,563
-46,754
| -79% | -$301K |
|
|
PCF
3817
High Income Securities Fund
PCF
$102M
| $79K | ﹤0.01% |
+14,363
| New | +$85.1K |
|
3818
Acurx Pharmaceuticals
ACXP
$6.62M
| $74K | ﹤0.01% |
+20,000
| New | +$56.7K |
|
3819
Coherus Oncology
CHRS
$181M
| $74K | ﹤0.01% |
43,576
-103
| -0.2% | -$183 |
|
3820
Rekor Systems
REKR
$94M
| $74K | ﹤0.01% |
89,935
+20
| +0% | +$21 |
|
3821
BlackRock TCP Capital
TCPC
$336M
| $72K | ﹤0.01% |
19,995
-3,784
| -16% | -$17.5K |
|
3822
B&G Foods
BGS
$291M
| $71K | ﹤0.01% |
14,661
-346
| -2% | -$1.68K |
|
3823
Milestone Pharmaceuticals
MIST
$141M
| $71K | ﹤0.01% |
59,620
+12,480
| +26% | +$21.9K |
|
3824
Champions Oncology
CSBR
$68.8M
| $70K | ﹤0.01% |
12,252
| – | – |
|
|
NHS
3825
Neuberger High Yield Strategies Fund Inc
NHS
$254M
| $69K | ﹤0.01% |
+10,595
| New | +$77.7K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Cambridge Investment Research Advisors held 4,122 positions worth $38.8B, up 2.5% from $37.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $1.75B of net new capital in Q1 2026, opening 310 new positions and adding to 2,005 existing holdings. Its largest new stake was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $35.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2026 buy was Hedgeye Capital Allocation ETF: 1,477,836 shares worth $42.7M.
- Cambridge Investment Research Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $140M increase.
- Cambridge Investment Research Advisors's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $35.4M.
- Cambridge Investment Research Advisors fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $7.82M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $38.8B portfolio in Q1 2026.
- Cambridge Investment Research Advisors opened 310 new positions and closed 198 in Q1 2026.
- Cambridge Investment Research Advisors's portfolio value rose 2.5% quarter-over-quarter to $38.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.